Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "sodium"

93 News Found

Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals
Biotech | March 15, 2022

Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals

A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing


Unichem receives ANDA approval for bipolar disorder drug
Drug Approval | February 28, 2022

Unichem receives ANDA approval for bipolar disorder drug

Divalproex Sodium Extended-Release tablets are indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, as monotherapy and adjunctive therapy and prophylaxis of migraine headaches


Azelis expands partnership with Roquette to strengthen India presence
News | February 24, 2022

Azelis expands partnership with Roquette to strengthen India presence

This new mandate builds upon and strengthens Azelis and Roquette’s global strategic partnership which spans multiple regions and industries.


Daewoong Pharmaceutical posts strong financials in 2021
News | February 22, 2022

Daewoong Pharmaceutical posts strong financials in 2021

Daewoong delivered KRW 1.055 trillion in sales, KRW 95.5 billion in operating profit and KRW 40.5 billion in net profit.


Amneal expands injectables portfolio with four new products
Drug Approval | February 19, 2022

Amneal expands injectables portfolio with four new products

Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market


US FDA to review Amylyx new drug application for AMX0035
Drug Approval | February 19, 2022

US FDA to review Amylyx new drug application for AMX0035

AMX0035 is an investigational therapy for the treatment of amyotrophic lateral sclerosis (ALS).


Novartis AG wins case against four domestic pharma firms
News | November 03, 2021

Novartis AG wins case against four domestic pharma firms

The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech


Glenmark launches novel fixed-dose combination for diabetes
Drug Approval | October 26, 2021

Glenmark launches novel fixed-dose combination for diabetes

It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination


WHO new Essential Medicines Lists focus on diabetes and cancer
Public Health | September 30, 2021

WHO new Essential Medicines Lists focus on diabetes and cancer

The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all


Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis
Public Health | September 14, 2021

Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis

Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor